Ms Vicky McGrath:

Okay. A positive reimbursement decision is not the end of the road. There is often a managed access program, which also adds delays, and there is not much capacity for novel therapies coming along, which adds further delays to the submission process.

Last year, in the run-up to the election, we sought a Government commitment to make OMPs available in Ireland within 12 months of EMA authorisation. I use this opportunity to reiterate this ask. We absolutely must strive to make all OMPs available to Irish patients within 12 months of authorisation over the lifetime of this Government. That does not necessarily mean that a drug is reimbursed, but we need early access programmes to be implemented as soon as possible.